22 related articles for article (PubMed ID: 38458013)
21. Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma.
Wei S; Wei F; Li M; Yang Y; Zhang J; Li C; Wang J
Biomed Pharmacother; 2023 Jul; 163():114798. PubMed ID: 37121146
[TBL] [Abstract][Full Text] [Related]
22. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma.
Wang Z; Zhou C; Zhang Y; Tian X; Wang H; Wu J; Jiang S
Biomed Pharmacother; 2024 Jan; 170():116074. PubMed ID: 38147732
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
